Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
Joseph S. Freedman reported a 9.00% stake in Eupraxia Pharmaceuticals, Inc. (Schedule 13D/A)
Event Mar 13, 2026 · Filed Mar 16, 2026
Joseph S. Freedman reported a 9.00% stake in Eupraxia Pharmaceuticals, Inc., 5,843,215 shares, with active intent on Mar 13, 2026. Filed Mar 16, 2026 (Schedule 13D/A).
- Stake
- 9.00%
- Shares
- 5,843,215
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Joseph S. Freedman | 9.00% | 5,843,215 |
Source
Related
- Eupraxia Pharmaceuticals, Inc.
- Joseph S. Freedman
- Eupraxia Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Joseph S. Freedman · Sep 26, 2025
- Schedule 13G/A · James E. Besser · Aug 13, 2026
- Schedule 13G/A · James E. Besser · May 12, 2026
- Schedule 13G/A · James E. Besser · Feb 17, 2026
- Schedule 13G/A · Robert Disbrow · Nov 14, 2025
- Schedule 13G · Beutel, Goodman & Co Ltd. · Nov 14, 2025